Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8636 |
High Similarity |
NPD920 |
Approved |
0.8616 |
High Similarity |
NPD3749 |
Approved |
0.8506 |
High Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8497 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8355 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8344 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8323 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8313 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8302 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8301 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8289 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8289 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8289 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8278 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8272 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8269 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8269 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8269 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8269 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8255 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8239 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8235 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8224 |
Intermediate Similarity |
NPD2796 |
Approved |
0.821 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8199 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8153 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8148 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8146 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8129 |
Intermediate Similarity |
NPD3750 |
Approved |
0.811 |
Intermediate Similarity |
NPD919 |
Approved |
0.8098 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8084 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8077 |
Intermediate Similarity |
NPD2309 |
Approved |
0.8039 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8025 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8013 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7949 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7939 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7935 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7914 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7901 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7882 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7866 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7849 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7844 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7818 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7811 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7806 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7798 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7785 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7771 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7756 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.775 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7733 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7719 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7716 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7703 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7684 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7677 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7673 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7667 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7657 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7647 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7632 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7605 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7598 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7593 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7588 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.758 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7572 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7558 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7558 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7558 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7545 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7545 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7544 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7544 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7544 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7532 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7532 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7532 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7529 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD3226 |
Approved |
0.75 |
Intermediate Similarity |
NPD2296 |
Approved |
0.75 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7486 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7483 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7458 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7434 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7429 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7429 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7421 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7421 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7403 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.74 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7394 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7389 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7386 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7386 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7384 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7381 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7381 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7378 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7375 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7375 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7375 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7375 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7351 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7347 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7345 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7345 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7341 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7337 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7325 |
Intermediate Similarity |
NPD943 |
Approved |
0.7308 |
Intermediate Similarity |
NPD411 |
Approved |
0.7308 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7299 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7278 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7263 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7257 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7251 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7251 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7251 |
Intermediate Similarity |
NPD4966 |
Approved |
0.725 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7208 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7207 |
Intermediate Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.7204 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7204 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7202 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7193 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7171 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD17 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7107 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7101 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7076 |
Intermediate Similarity |
NPD37 |
Approved |
0.7074 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7059 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7059 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7037 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7033 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7033 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7032 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7032 |
Intermediate Similarity |
NPD3225 |
Approved |
0.703 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7024 |
Intermediate Similarity |
NPD6273 |
Approved |
0.702 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7017 |
Intermediate Similarity |
NPD6764 |
Approved |
0.7017 |
Intermediate Similarity |
NPD6765 |
Approved |
0.7006 |
Intermediate Similarity |
NPD9494 |
Approved |
0.6988 |
Remote Similarity |
NPD3887 |
Approved |
0.6988 |
Remote Similarity |
NPD2354 |
Approved |
0.6987 |
Remote Similarity |
NPD1164 |
Approved |
0.6983 |
Remote Similarity |
NPD7228 |
Approved |
0.6983 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6981 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6968 |
Remote Similarity |
NPD4749 |
Approved |
0.6928 |
Remote Similarity |
NPD1778 |
Approved |
0.6923 |
Remote Similarity |
NPD6104 |
Discontinued |
0.6914 |
Remote Similarity |
NPD6971 |
Discontinued |
0.6913 |
Remote Similarity |
NPD1241 |
Discontinued |
0.691 |
Remote Similarity |
NPD5242 |
Approved |
0.6905 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6894 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.689 |
Remote Similarity |
NPD5404 |
Approved |
0.689 |
Remote Similarity |
NPD4477 |
Approved |
0.689 |
Remote Similarity |
NPD5408 |
Approved |
0.689 |
Remote Similarity |
NPD5406 |
Approved |
0.689 |
Remote Similarity |
NPD4476 |
Approved |
0.689 |
Remote Similarity |
NPD5405 |
Approved |
0.6875 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.6875
|
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |